Recognizing the signs of mild cognitive impairment meant Di could start treatment earlier to help slow her Alzheimer's ...
Scientists say a simple at-home test could spot someone's risk of Alzheimer's disease before symptoms take hold, in what ...
With nearly 95,000 Louisianans living with Alzheimer's disease, family caregivers play a vital role in home-based dementia ...
As Alzheimer's disease and other dementias continue to rise nationwide, new research shows that equipping primary care ...
Scientists unveil Alzheimer’s finger prick test to predict risk of disease - Researchers found the blood test can be used ...
The progressive brain disorder causes symptoms similar to Parkinson's disease in addition to memory and cognitive declines.
Researchers at UC San Diego say they recently uncovered new insights into a protein that has emerged as a potential molecular ...
US FDA approves Axsome Therapeutics’ Auvelity to treat agitation associated with dementia due to Alzheimer’s disease: New York Monday, May 4, 2026, 12:30 Hrs [IST] Axsome Ther ...
AUVELITY is a first-in-class treatment, which targets the NMDA and sigma-1 receptors, approved for agitation associated with ...
People have no control over Alzheimer's risk factors such as age, genes and family history. Diet, exercise and adequate sleep ...
A: My name is Dr. Jennifer Pauldurai and I am an Inova cognitive behavioral neurologist. I help people with changes in thinking and memory. Q: What exactly is Alzheimer’s disease, and how common is it ...
MedPage Today on MSN
FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation
Oral NMDA receptor antagonist gets an expanded indication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results